In HD, dysregulation of CREB-mediated transcription and/or activity of its cofactors causes a reduction in BDNF levels [409], altered NMDA signalling, and diminished activation of the MAPK/ERK and protein kinase A pathways [408,410]. This evidence concerns the gene CREB1 and Huntington disease.